Literature DB >> 18505888

Clinical and laboratory diagnosis of the metabolic syndrome.

R Olufadi1, C D Byrne.   

Abstract

The epidemic of obesity is largely responsible for the high prevalence of metabolic syndrome in the developed world. Since 2001 with the development of the NCEP metabolic syndrome classification, simple pragmatic criteria have been available that can be applied in primary care across all continents to diagnose the syndrome. Although there is an ongoing debate about the level of thresholds that should be applied to individual features of the syndrome, it is likely that with further research a consensus will be reached in the near future. It is now clear that metabolic syndrome represents a condition of insulin resistance and ectopic fat accumulation associated with a proinflammatory and procoagulant phenotype. The syndrome is sometimes associated with other conditions such as non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome, type 2 diabetes and cardiovascular disease. The purpose of this review is to discuss the clinical and laboratory diagnosis of the metabolic syndrome. The review discusses the various approaches to the investigation of people with the metabolic syndrome. Simple tools for clinical and laboratory diagnosis of metabolic syndrome are described. Some of the more complex biochemical tests that are now being applied in research to the diagnosis of associated conditions, such as NAFLD, are also described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505888     DOI: 10.1136/jcp.2007.048363

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

1.  NOX activity in brain aging: exacerbation by high fat diet.

Authors:  Annadora J Bruce-Keller; Christy L White; Sunita Gupta; Alecia G Knight; Paul J Pistell; Donald K Ingram; Christopher D Morrison; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2010-03-25       Impact factor: 7.376

2.  IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

Authors:  Luis A Zúñiga; Wen-Jun Shen; Barbara Joyce-Shaikh; Ekaterina A Pyatnova; Andrew G Richards; Colin Thom; Sofia M Andrade; Daniel J Cua; Fredric B Kraemer; Eugene C Butcher
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 3.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

4.  The relevance of inflammatory markers in metabolic syndrome.

Authors:  Genel Sur; Emanuela Floca; Liana Kudor-Szabadi; Maria Lucia Sur; Daniel Sur; Gabriel Samasca
Journal:  Maedica (Buchar)       Date:  2014-03

Review 5.  Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology.

Authors:  Tamara N Dunn; Sean H Adams
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

6.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

Review 7.  Obesity and vulnerability of the CNS.

Authors:  Annadora J Bruce-Keller; Jeffrey N Keller; Christopher D Morrison
Journal:  Biochim Biophys Acta       Date:  2008-10-17

8.  Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.

Authors:  Patrick M Heck; Stephen P Hoole; Sadia N Khan; David P Dutka
Journal:  Cardiovasc Diabetol       Date:  2010-06-24       Impact factor: 9.951

9.  A new mouse model of metabolic syndrome and associated complications.

Authors:  Yun Wang; Yue Zheng; Patsy M Nishina; Jürgen K Naggert
Journal:  J Endocrinol       Date:  2009-04-27       Impact factor: 4.286

Review 10.  Pathogenesis of non-alcoholic fatty liver disease.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  QJM       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.